Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2

Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2

Bibliographic Details
Main Authors:	Yifan Lin, Jing Sun, Xuezhi Cao, Xiuye Wang, Xi Chen, Hairong Xu, Jincun Zhao, Yang-Xin Fu, Hua Peng
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-05-01
Series:	Cell Discovery
Online Access:	https://doi.org/10.1038/s41421-022-00411-4

Similar Items

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
by: Juan Shi, et al.
Published: (2023-03-01)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
by: Hong Lei, et al.
Published: (2020-12-01)

Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models
by: Ricardo Choque-Guevara, et al.
Published: (2022-01-01)

Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models.
by: Ricardo Choque-Guevara, et al.
Published: (2022-01-01)

Impact of glycosylation and length of RBD of SARS-CoV-2 S protein on the immunogenicity of RBD protein vaccines
by: ZHANG Ting, WANG Zhi-rong, XU Xue-mei
Published: (2020-12-01)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
by: Xiaofeng Liu, et al.
Published: (2023-01-01)

Antibodies and Vaccines Target RBD of SARS-CoV-2
by: Long Min, et al.
Published: (2021-04-01)

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
by: Nanda Kishore Routhu, et al.
Published: (2021-06-01)

The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination
by: Jingyi Yang, et al.
Published: (2023-04-01)

Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
by: Changcai Teng, et al.
Published: (2022-12-01)

The Influence of Adjuvant Type on the Immunogenicity of RBD/N Cocktail Antigens as a Vaccine Candidate against SARS-CoV-2 Virus
by: Gabriela Brzuska, et al.
Published: (2023-06-01)

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia
by: Andrés Pizzorno, et al.
Published: (2020-07-01)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
by: Guillaume Gerez, et al.
Published: (2022-08-01)

Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
by: Sakshi Bajoria, et al.
Published: (2022-11-01)

Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
by: Etsuro Nanishi, et al.
Published: (2023-02-01)

Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults
by: Karina A. Pasquevich, et al.
Published: (2023-07-01)

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses
by: Yidan Qiao, et al.
Published: (2022-12-01)

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
by: Yi-Sheng Sun, et al.
Published: (2021-09-01)

An Algae-Made RBD from SARS-CoV-2 Is Immunogenic in Mice
by: Dania O. Govea-Alonso, et al.
Published: (2022-10-01)

Application and Validation of SARS-CoV-2 RBD Neutralizing ELISA Assay
by: Z. S Mousa, et al.
Published: (2022-02-01)

Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
by: Ting-Wei Lin, et al.
Published: (2022-10-01)

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
by: Guoli Shi, et al.
Published: (2024-01-01)

Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication
by: Elizabeth R. Vanderwall, et al.
Published: (2022-04-01)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
by: Larissa R. Gomes, et al.
Published: (2021-09-01)

RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor
by: Siddharth Sinha, et al.
Published: (2021-12-01)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
by: Daniel Junker, et al.
Published: (2022-05-01)

Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
by: Etsuro Nanishi, et al.
Published: (2023-03-01)

Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling
by: Chao-Hung Chen, et al.
Published: (2022-05-01)

RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
by: Ting Y. Wong, et al.
Published: (2022-08-01)

Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses
by: Melika Haghighi, et al.
Published: (2022-05-01)

Studies on immunoreceptor activation and SARS-CoV-2 RBD/ACE2 interactions
by: Barton, MI
Published: (2022)

Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity
by: Lucy Rutten, et al.
Published: (2024-03-01)

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
by: Emily E. F. Brown, et al.
Published: (2021-02-01)

Maximization of the Minicircle DNA Vaccine Production Expressing SARS-CoV-2 RBD
by: Cathy Ventura, et al.
Published: (2022-04-01)

A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity
by: Qiaoqiao Qu, et al.
Published: (2022-11-01)

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
by: Lin Yang, et al.
Published: (2021-11-01)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
by: Camryn Carter, et al.
Published: (2023-10-01)

Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice
by: Siyu Tian, et al.
Published: (2021-10-01)

Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
by: Xi Chen, et al.
Published: (2022-08-01)

Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium
by: Satria P. Sajuthi, et al.
Published: (2020-10-01)